Skip to main content
Premium Trial:

Request an Annual Quote

Correction:: Sep 16, 2002


In the 08-05-02 issue of BioInform, the article, “Inpharmatica Makes Good on its Discovery Plans, Commits to Stay in Data Business,” incorrectly stated the starting price for Biotech Biopendium as $225,000. The correct price is $275,000.

Filed under

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.